Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A pivotal clinical phamacodynamic study of Zoreline one-month formulation

X
Trial Profile

A pivotal clinical phamacodynamic study of Zoreline one-month formulation

Status: Planning
Phase of Trial: Phase III

Latest Information Update: 15 Mar 2022

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Goserelin (Primary)
  • Indications Breast cancer; Endometriosis; Prostate cancer
  • Focus Pharmacodynamics; Registrational
  • Sponsors Mithra Pharmaceuticals
  • Most Recent Events

    • 08 Mar 2022 According to a Mithra Pharmaceuticals media release, the company expect to launch this trial at the end of 2022 or begin of 2023.
    • 01 Mar 2019 According to a Mithra Pharmaceuticals media release, the study is plannned to be initiated in second half of 2019. Based on results of this study the company plans to file for marketing authorization via patners.
    • 09 Jan 2019 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top